Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Advanced or Metastatic Gastric Cancer
NCT00595985Phase 2Terminated
- Sponsor
- Fudan University
- Start
- Jul 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in gastric adenocarcinoma, sponsored by Fudan University. Started Jul 2007; status: terminated.
02
Drugs
sorafenib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00595985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595985.